Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Lara

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 9, 2021
Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic diseaseOscar Arrieta, Alejandro Avilés Salas, Andrés F Cardona, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung CancerAlejandro Avilés-Salas, Diego A Díaz-García, Luis Lara-Mejía, et al.
Frontiers in Psychology|January 22, 2026
Cancer as trauma: multidimensional determinants of PTSD across the disease course. A narrative integrative reviewCittim B Palomares-Palomares, Eduardo Rios-Garcia, Juan-Manuel Hernandez-Martinez, et al.
Cancer Biomarkers : Section a of Disease Markers|May 31, 2021
Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIsOscar Arrieta, Juan-Manuel Hernandez-Martinez, Edgar Montes-Servín, et al.
Clinical Lung Cancer|May 5, 2021
Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung CancerOscar Arrieta, Edgar Varela-Santoyo, Andrés F Cardona, et al.
Animals : an Open Access Journal From MDPI|October 16, 2024
Bioavailability of Supplemented Free Oleanolic Acid and Cyclodextrin-Oleanolic Acid in Growing Pigs, and Effects on Growth Performance, Nutrient Digestibility and Plasma MetabolitesManuel Lachica, Isabel Borrás-Linares, Thays Helena Borges, et al.
Pathology Oncology Research : POR|July 14, 2021
Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor CellsGraciela Cruz-Rico, Alejandro Avilés-Salas, Xitlally Popa-Navarro, et al.
Nature Communications|May 16, 2025
Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trialOscar Arrieta, Luis Lara-Mejía, Eduardo Rios-Garcia, et al.
Clinical Lung Cancer|February 4, 2025
Elucidating the Role of EGFR<sup>L858R</sup> in Brain Metastasis Among Patients With Advanced NSCLC Undergoing TKI TherapyEduardo Rios-Garcia, Alberto Guijosa, Enrique Caballé-Perez, et al.
ANS. Advances in Nursing Science|January 17, 2023
"Nursing (Her) Storytelling": An Ethnographic Fiction Proposal for Exploring Feminist Health Activism in SpainAlmudena Alameda-Cuesta, Irene Blanco-Fuente, Amparo Bonilla-Campos, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Lung Cancer (Amsterdam, Netherlands)|February 9, 2021
Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic diseaseOscar Arrieta, Alejandro Avilés Salas, Andrés F Cardona, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung CancerAlejandro Avilés-Salas, Diego A Díaz-García, Luis Lara-Mejía, et al.
Frontiers in Psychology|January 22, 2026
Cancer as trauma: multidimensional determinants of PTSD across the disease course. A narrative integrative reviewCittim B Palomares-Palomares, Eduardo Rios-Garcia, Juan-Manuel Hernandez-Martinez, et al.
Cancer Biomarkers : Section a of Disease Markers|May 31, 2021
Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIsOscar Arrieta, Juan-Manuel Hernandez-Martinez, Edgar Montes-Servín, et al.
Clinical Lung Cancer|May 5, 2021
Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung CancerOscar Arrieta, Edgar Varela-Santoyo, Andrés F Cardona, et al.
Animals : an Open Access Journal From MDPI|October 16, 2024
Bioavailability of Supplemented Free Oleanolic Acid and Cyclodextrin-Oleanolic Acid in Growing Pigs, and Effects on Growth Performance, Nutrient Digestibility and Plasma MetabolitesManuel Lachica, Isabel Borrás-Linares, Thays Helena Borges, et al.
Pathology Oncology Research : POR|July 14, 2021
Association of Lung Adenocarcinoma Subtypes According to the IASLC/ATS/ERS Classification and Programmed Cell Death Ligand 1 (PD-L1) Expression in Tumor CellsGraciela Cruz-Rico, Alejandro Avilés-Salas, Xitlally Popa-Navarro, et al.
Nature Communications|May 16, 2025
Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): a single-arm, phase 2 trialOscar Arrieta, Luis Lara-Mejía, Eduardo Rios-Garcia, et al.
Clinical Lung Cancer|February 4, 2025
Elucidating the Role of EGFR<sup>L858R</sup> in Brain Metastasis Among Patients With Advanced NSCLC Undergoing TKI TherapyEduardo Rios-Garcia, Alberto Guijosa, Enrique Caballé-Perez, et al.
ANS. Advances in Nursing Science|January 17, 2023
"Nursing (Her) Storytelling": An Ethnographic Fiction Proposal for Exploring Feminist Health Activism in SpainAlmudena Alameda-Cuesta, Irene Blanco-Fuente, Amparo Bonilla-Campos, et al.
Pageof 8